28 results
management diagnosis treatment hivaids idsa infectiousdiseases prevention differential activetb latenttb rheumatology tb tuberculosis algorithm diabetes dm2 endocrinology fungal indications lung
COVID-19: ICU Guidelines for the Non-Intensivist Infection Control Risk Factors for Severe Disease Initial Laboratory Workup COVID-19 Specific Medications Respiratory Cardiac Hematologic Neuro/Sedation #COVID19 #ICU
Non-Intensivist Infection ... Control Risk Factors ... for Severe Disease ... #COVID19 #ICU #criticalcare
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS Preventing Clinical Disease Indication: Individuals
with epidemic risk ... patients are still at risk ... Treatment #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
SGLT2 Inhibitors - Pharmacology Summary Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
Jardiance) - Best risk ... mortality in high risk ... atherosclerotic heart disease ... hypovolemia) • GU infections ... Canagliflozin ↑ risk
Tuberculosis Overview 10 million new M. tuberculosis infections/year Facultative intracellular rod-shaped bacteria Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
lymph nodes Risk ... • Pulmonary fibrotic ... Chronic kidney disease ... • HIV: 2/3 pulmonary ... Inhibitor: • Risk
GLP-1 Receptor Agonists - Pharmacology Summary Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... outcomes in high risk ... atherosclerotic heart disease ... effect) • May ↑ risk ... Receptor #Agonists #Pharmacology
Preoperative Risk Evaluation Major Pre-Op Questions: 1. Does the patient have any modifiable risk factors that could be
murmur 3/6) - Pulmonary ... Skin exam for infection ... Ischemic heart disease ... : - Known CV disease ... days before Pulmonary
Tuberculosis Overview 10 million new M. tuberculosis infections/year Facultative intracellular rod-shaped bacteria Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
lymph nodes Risk ... • Pulmonary fibrotic ... Chronic kidney disease ... • HIV: 2/3 pulmonary ... Inhibitor: • Risk
Tuberculosis Testing LATENT TB • LTBI is diagnosed when an asymptomatic patient has a positive TST or IGRA
to decrease the risk ... • The lifetime risk ... or intermediate risk ... of disease progression ... used to exclude pulmonary
Hydroxychloroquine - Risks and Benefits in Lupus Benefits: ↓ Disease activity, ↓ Flare, ↓ Damage, ↓ Corticosteroid dose,
Benefits: ↓ Disease ... Thrombosis, ↓ Severe infection ... Cardiovascular risk ... deficiency [(limited) risk ... Benefits #Lupus #pharmacology
Invasive Aspergillus (IA) - Diagnosis and Management Aspergillus is ubiquitous in nature. Most invasive infections are caused
Most invasive infections ... complex Classic Risk ... presentations: • Pulmonary ... , Disseminated infection ... Diseases Fellows
No results found for "Disk criticalcare risk pulmonary pharmacology infections gastroenterology opportunistic disease"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Disk #criticalcare #risk #pulmonary #pharmacology #infections #gastroenterology #opportunistic #disease